Davendra Sohal, MD of Cleveland Clinic gives and update on the SWOG S1505 A randomized phase II study of perioperative mFOLFIRINOX vs. gemcitabine/nab-paclitaxel as therapy for resectable pancreatic adenocarcinoma at ASCO GI 2017
Update SWOG S1505 from Annual Meeting GI 2017
